Inclisiran as a siRNA Inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Past, Present, and Future
Taha Mansoor, B. S. Narasinga Rao, Kartik Gupta, Sachin S. Parikh, Dmitry Abramov, Anurag Mehta, Mahmoud Al Rifai, Salim S. Virani, Vijay Nambi, Abdul Mannan Khan Minhas, Santhosh Koshy
Topics & Concepts
PCSK9KexinProprotein convertaseMedicineSubtilisinPharmacologyStatinClinical trialDrugAdverse effectLDL receptorInternal medicineCholesterolLipoproteinBiochemistryChemistryEnzymeLipoproteins and Cardiovascular HealthComputational Drug Discovery MethodsMicrobial Metabolism and Applications